KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Short-term Investments (2016 - 2025)

Edwards Lifesciences has reported Short-term Investments over the past 15 years, most recently at $1.3 billion for Q4 2025.

  • Quarterly results put Short-term Investments at $1.3 billion for Q4 2025, up 38.42% from a year ago — trailing twelve months through Dec 2025 was $1.3 billion (up 38.42% YoY), and the annual figure for FY2025 was $1.3 billion, up 38.42%.
  • Short-term Investments for Q4 2025 was $1.3 billion at Edwards Lifesciences, up from $1.2 billion in the prior quarter.
  • Over the last five years, Short-term Investments for EW hit a ceiling of $1.3 billion in Q4 2025 and a floor of $156.4 million in Q1 2021.
  • Median Short-term Investments over the past 5 years was $469.8 million (2023), compared with a mean of $566.5 million.
  • Biggest five-year swings in Short-term Investments: crashed 57.52% in 2021 and later soared 197.31% in 2022.
  • Edwards Lifesciences' Short-term Investments stood at $604.0 million in 2021, then dropped by 26.11% to $446.3 million in 2022, then increased by 12.14% to $500.5 million in 2023, then soared by 85.95% to $930.7 million in 2024, then surged by 38.42% to $1.3 billion in 2025.
  • The last three reported values for Short-term Investments were $1.3 billion (Q4 2025), $1.2 billion (Q3 2025), and $789.4 million (Q2 2025) per Business Quant data.